Antiretroviral therapy (ART) is highly effective at controlling HIV infections, but the virus never completely goes away. Instead, it hides in roughly one in every 1 million immune cells.
Mar 23, 2022
0
107
A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ...
Feb 1, 2022
0
65
Across Australia, there were 633 new diagnoses of HIV in 2020, a decline of 30 percent since 2019, according to new data released today on World AIDS Day by the Kirby Institute at UNSW Sydney.
Dec 1, 2021
0
26
The number of people with HIV using antiretroviral therapy (ART) to suppress the virus could increase as much as 36 percent by the end of the decade and includes more older people, representing a continued public health burden, ...
Nov 30, 2021
0
5
An observational study found that gender/sex disparities in the use of dolutegravir-containing antiretroviral therapy (ART) persist despite World Health Organization (WHO) endorsement for its use among women with HIV of reproductive ...
Nov 30, 2021
0
3
Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and ...
Nov 29, 2021
0
12
HIV patients have an increased risk of developing skin and mucosal cancers, even though HIV is no longer detectable in their blood due to antiretroviral therapy. A new study by MedUni Vienna's Department of Dermatology, the ...
Nov 23, 2021
0
13
Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical ...
Oct 28, 2021
0
74
A randomized controlled trial found that the addition of genotypic resistance testing to routine care did not improve virologic suppression among persons whose first-line antiretroviral therapy (ART) failed in public-sector ...
Oct 26, 2021
0
4
Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional ...
Oct 21, 2021
0
131
